Suchergebnisse - "Itolizumab"

PubPharm (27)

11

Scientists criticize use of unproven COVID drugs in India

enthalten in: Nature | 2020

von Vaidyanathan, G.

12

Anti-CD6 mAbs for the treatment of psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Dogra, S. | D, S. | Rajagopalan, M.

13

Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications

enthalten in: Expert opinion on biological therapy | 2020

von Loganathan, S. | Athalye, S. | Joshi, S.

14

Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

enthalten in: Gerontology | 2020

von Díaz, Y. | Ramos-Suzarte, M. | Martín, Y. | +17

15

New Targeted Therapies for Uncontrolled Asthma

enthalten in: The journal of allergy and clinical immunology. In practice | 2019

von Corren, J.

16

Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis : A network meta-analysis

enthalten in: Journal of pharmacological sciences | 2019

von Xu, G. | Xia, M. | Jiang, C. | +4

17

The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients : results from a 6-month, open-label Phase I clinical trial

enthalten in: Clinical and experimental immunology | 2018

von Rodríguez, P. | Prada, D. | Moreno, E. | +15

18

Itolizumab, a novel anti-CD6 monoclonal antibody : a safe and efficacious biologic agent for management of psoriasis

enthalten in: Expert opinion on biological therapy | 2017

von Dogra, S. | Uprety, S. | Suresh, S.

19

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab

enthalten in: PloS one | 2017

von Bughani, U. | Saha, A. | Kuriakose, A. | +11

ErratumIn: PLoS One. 2018 Jan 30;13(1):e0192335. - PMID 29381749

20

Severe recalcitrant psoriasis treated with itolizumab, a novel anti-CD6 monoclonal antibody

enthalten in: Indian journal of dermatology, venereology and leprology | 2016

von Gupta, A. | Sharma, Y. | Deo, K. | +1